UXS1 and fatty liver disease: Knockdown of UXS1 had no effect on hepatic steatosis and hepatic TG, TC and NEFA levels (Supplementary Fig. 9c, d), or macrophage infiltration and pro-inflammatory markers expression in livers of CD-HFD-fed mice (Supplementary Fig. 9e, f).